Development Expenses. Novartis shall be solely responsible for the costs and expenses of Developing and commercializing Licensed Products pursuant to the terms of this Agreement, except with respect to Infinity’s research, development and commercialization activities with respect to an Abandoned Profile pursuant to Section 3.3.1 (subject to Section 2.3).
Appears in 5 contracts
Samples: Collaboration Agreement, Collaboration Agreement (Discovery Partners International Inc), Collaboration Agreement (Infinity Pharmaceuticals, Inc.)
